SKOLD v. GALDERMA LABORATORIES, L.P. et al

Filing 196

MEMORANDUM AND ORDER THAT DEFENDANTS MOTION FOR JUDGMENT AS A MATTER OF LAW (DOC. 187) IS GRANTED IN PART AND DENIED IN PART AS OUTLINED HEREIN. PLAINTIFFS MOTION FOR JUDGMENT AS A MATTER OF LAW (DOC. 188) IS GRANTED IN PART AND DENIED IN PART AS OUTLINED HEREIN. JUDGMENT ENTERED BY THE COURT ON 3/1/17 (DOC. 185) IS HEREBY VACATED. SIGNED BY HONORABLE WENDY BEETLESTONE ON 8/29/17. 8/30/17 ENTERED AND COPIES EMAILED.(rf, )

IN THE UNITED STATES DISTRICT COURT
FOR THE EASTERN DISTRICT OF PENNSYLVANIA
THOMAS SKOLD,

CIVIL ACTION
Plaintiff,

v.
GALDERMA LABORATORIES, L.P., et
al.,
Defendants.

NO. 14-5280

ORDER
AND NOW, this 29th day of August, 2017, upon consideration of Defendants’ Motion
for Judgment as a Matter of Law (ECF No. 187); Plaintiff’s Response in Opposition thereto
(ECF No. 190); Defendant’s Reply (ECF No. 191); Plaintiff’s Motion for Judgment as a Matter
of Law and/or For New Trial (ECF No. 188); Defendants’ Response in Opposition thereto (ECF
No. 189); and Plaintiff’s Reply (ECF No. 192), for the reasons set forth in the accompanying
Opinion, IT IS ORDERED that:
(1) Defendants’ Motion for Judgment as a Matter of Law (ECF No. 187) is GRANTED
in part and DENIED in part as follows:
a. Defendants’ Motion is GRANTED insofar as the judgment should reflect a
costs award only against Defendants Galderma Laboratories, L.P., Galderma
S.A., and Nestlé Skin Health S.A.; and
b. Defendants’ Motion is DENIED in all other respects.
(2) Plaintiff’s Motion for Judgment as a Matter of Law (ECF No. 188) is GRANTED in
part and DENIED in part as follows:
a. Plaintiff’s Motion is GRANTED insofar as he moves for declaratory relief on
his unjust enrichment claim.

b. Plaintiff’s Motion is DENIED in all other respects.
(3) Plaintiff’s Motion for New Trial (ECF No. 188) is DENIED.
(4) The Judgment entered by the Court on March 1, 2017 (ECF No. 185) is hereby
VACATED.

BY THE COURT:

/s/Wendy Beetlestone, J.

WENDY BEETLESTONE, J.

2